The potential skin-lightening candidate, senolytic drug ABT263, for photoageing pigmentation
- PMID: 34773647
- DOI: 10.1111/bjd.20893
The potential skin-lightening candidate, senolytic drug ABT263, for photoageing pigmentation
References
-
- Fitsiou E, Pulido T, Campisi J et al. Cellular senescence and the senescence-associated secretory phenotype as drivers of skin photoaging. J Invest Dermatol 2021; 141 (Suppl. 4):1119-26.
-
- Kirkland JL, Tchkonia T, Zhu Y et al. The clinical potential of senolytic drugs. J Am Geriatr Soc 2017; 65:2297-301.
-
- Yoon JE, Kim Y, Kwon S et al. Senescent fibroblasts drive ageing pigmentation: a potential therapeutic target for senile lentigo. Theranostics 2018; 8:4620-32.
-
- Kang HY, Lee JW, Papaccio F et al. Alterations of the pigmentation system in the aging process. Pigment Cell Melanoma Res 2021; 34:800-13.
-
- Kovacs D, Cardinali G, Aspite N et al. Role of fibroblast-derived growth factors in regulating hyperpigmentation of solar lentigo. Br J Dermatol 2010; 163:1020-7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
